| Literature DB >> 26568767 |
Xian-Liang Liu1, Jing-Yu Tan2, Alex Molassiotis2, Lorna K P Suen2, Yan Shi3.
Abstract
The purpose of this study was to evaluate the effectiveness of Acupuncture-point stimulation (APS) in postoperative pain control compared with sham/placebo acupuncture or standard treatments (usual care or no treatment). Only randomized controlled trials (RCTs) were included. Meta-analysis results indicated that APS interventions improved VAS scores significantly and also reduced total morphine consumption. No serious APS-related adverse effects (AEs) were reported. There is Level I evidence for the effectiveness of body points plaster therapy and Level II evidence for body points electroacupuncture (EA), body points acupressure, body points APS for abdominal surgery patients, auricular points seed embedding, manual auricular acupuncture, and auricular EA. We obtained Level III evidence for body points APS in patients who underwent cardiac surgery and cesarean section and for auricular-point stimulation in patients who underwent abdominal surgery. There is insufficient evidence to conclude that APS is an effective postoperative pain therapy in surgical patients, although the evidence does support the conclusion that APS can reduce analgesic requirements without AEs. The best level of evidence was not adequate in most subgroups. Some limitations of this study may have affected the results, possibly leading to an overestimation of APS effects.Entities:
Year: 2015 PMID: 26568767 PMCID: PMC4620376 DOI: 10.1155/2015/657809
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Flow chart of the study selection process. CINAHL, Cumulative Index to Nursing and Allied Health Literature; AMED, Allied and Complementary Medicine Database; CBMdisc, Chinese Biological Medical Literature Database; CNKI, China National Knowledge Infrastructure.
Qualitative modified approach to grading of evidence.
| Level | Description |
|---|---|
| I | Evidence obtained from multiple relevant high quality randomized controlled trials |
|
| |
| II | Evidence obtained from at least one relevant high quality randomized controlled trial or multiple relevant moderate or low quality randomized controlled trials |
|
| |
| III | Evidence obtained from at least one relevant moderate or low quality randomized controlled trial with multiple relevant observational studies, or |
|
| |
| IV | Evidence obtained from multiple moderate or low quality relevant observational studies |
|
| |
| V | Opinion or consensus of large group of clinicians and/or scientists |
Source: [27].
Characteristics of RCTs examining body acupoint stimulation included in the meta-analysis.
| First author, year, setting | Study design | Participants ( | Surgery type | APS type | Intervention (acupoints, parameters) | Follow-up | Main outcomes | |
|---|---|---|---|---|---|---|---|---|
| Intervention group | Sham/control group | |||||||
| An, | Double-blind | Randomized = 120 | Supratentorial tumor resection | EA | EA/TEAS groups: LI4/TE5, BL63/LV3, ST36/GB40 | Standard treatment | NR | VAS, recovery time, AE, PCA |
|
| ||||||||
| Yin, | RCT | Randomized = 60 | Gynecological laparoscopic surgery | EA | ST36 and ST34 | General anesthesia | NR | VAS, PONV, exhaust defecation |
|
| ||||||||
| Taghavi, | Randomized, double-blind, placebo- | Randomized = 90, 25 (5) | Inguinal surgeries | EA | LI4 and SD36 | No electrical excitement through needles | NR | VAS, PCA, vital signs, side effects |
|
| ||||||||
| Zhang, | RCT | Randomized = 80 | Hemorrhoidectomy | EA | BL30 | 50 mg tramadol hydrochloride | NR | VAS, edema score, analgesics requirement, AE |
|
| ||||||||
| Lan, | RCT | Randomized = 68 | Total knee arthroplasty | EA | Bilateral P6, L14; ST36, and GB31 | Stimulation 30 min before incision at 0 mA | NR | Analgesics, VAS, RSS, AE |
|
| ||||||||
| Chen, | RCT | Randomized = 70 | Total knee arthroplasty | EA | SP10, ST34, ST35, EX-LE4, GB34 | Routine rehabilitation therapy | 12 weeks post-op | HSS, ROM, VAS, MMT |
|
| ||||||||
| Coura, | Prospective, randomized, controlled study | Randomized = 22 | Cardiac surgery | EA | LI4–LI11, LR3–ST36, and PC6–TE5 acupoints | LI4–LI11, LR3–ST36 acupoints; device turned off but connected, 30 min | NR | Analgesics/boluses required, VAS, hospitalization length |
|
| ||||||||
| Yeh, | Single-blind, randomized, placebo- | Randomized = 90 | Spinal surgery | EA | BL40, GB34, HT7, P6s | Sham: same acupoints, not meridian acupoints | NR | VAS, BPI, opiate requirement |
|
| ||||||||
| Deng, | RCT | Randomized = 60 | Gastrectomy, proctocolectomy | EA | LI4, PC8, ST25, and BL25 acupoints | Simple general anesthesia | NR | VAS, satisfaction, somnus score, PCA, BP, HR, SpO2, PONV |
|
| ||||||||
| Sahmeddini, | Randomized, double-blind | Randomized = 90 | Septoplasty | EA | LI4, LI11, HT7, HC6 acupoints | EA system pasted over hand without needle and stimulation. | NR | VAS, pulse rate, arterial pressure, AE |
|
| ||||||||
| Colak, | RCT | Randomized = 30 | Coronary surgery | EA | LI4, LI11, ST36, PC6, LIV3 | Pharmacological analgesia | NR | VAS, analgesic intake, pulmonary function, postoperative complications |
|
| ||||||||
| Larson, | Single-blind | Randomized = 122 | Outpatient plastic surgery | EA | P6 | Standardized pharmacological treatment | NR | Nausea, vomiting, pain, medications required, hospitalization length |
|
| ||||||||
| El-Rakshy, | Randomized, double-blind, comparative | Randomized = 107 | Abdominal hysterectomy, laparoscopic cholecystectomy | EA | Bilateral CV2, GV4, BL32, BL23, LI4, PC6; LR3, SP6, L14, PC6 | Morphine sulfate via PCA | NR | Morphine requirement, pain, nausea, vomiting |
|
| ||||||||
| He, | RCT | Randomized = 60 | Radical surgery for intestinal cancer | EA | “E pang 3 line” and “Ding pang 1 line” acupoints | Epidural analgesia at end of operation | NR | VAS, BCS, gastrointestinal function |
|
| ||||||||
| Wong, | Randomized, double-blind, placebo- | Randomized = 27 | Thoracotomy | EA | LI4, GB34, GB36, TE8 acupoints | Same acupoints, mimic prick sensation without piercing skin | NR | Peak flow rate, chest drain, VAS, PCA, complications |
|
| ||||||||
| Gilbertson, | RCT | Randomized = 40 | Arthroscopic acromioplasty | EA | Acupoints chosen with primary expectation of localized benefit to the operated shoulder | Similar to true acupoints and needles, connected but not functioning, blinking red light | 4 mos. | UCLA, VAS, |
|
| ||||||||
| Lin, | RCT, four | Randomized = 100 | Lower abdominal surgery | EA | ST36 acupoint | Control group: no stimulation | NR | VAS, analgesic, PCA demand, HR, BP, SpO2, opioid-related AE |
|
| ||||||||
| Sim, | RCT, three | Randomized = 90 | Gynecological lower abdominal surgery | EA | ST36 and PC6 acupoints | Control group: 45 min placebo EA | NR | VAS, morphine requirement, AE, satisfaction |
|
| ||||||||
| Chen, | RCT | Randomized = 100 | Total abdominal hysterectomy, myomectomy | EA | Dermatomal TENS: dermatomal levels corresponding to incision. | Sham: no electrical stimulation | NR | VAS, PCA demand, analgesic, recovery time, AE |
|
| ||||||||
| Wang, | Prospective, randomized, sham-controlled, single-blind | Randomized = 101 | Lower abdominal surgery | EA | LI4 acupoint | PCA only | NR | Hospitalization length, VAS, analgesia required, PCA need, AE, recovery time |
|
| ||||||||
| Masuda, | Controlled study | Randomized = 24 | Eye surgery | EA | “Gohkoku” (Hoku) and “Shikoh” (Chikkou) acupoints | Usual neuroleptanesthesia without acupuncture | NR | Pain, anesthetics required, swelling circulatory, |
|
| ||||||||
| Kim, | Double-blind, placebo- and sham-controlled study | Randomized = 84 | Orthognathic surgery | Plaster therapy | Bilateral LI4 acupoints | Sham: inactive tape | NR | VAS, PCA, AE, PONV, satisfaction score |
|
| ||||||||
| Kim, | Double-blind, placebo- and sham-controlled study | Randomized = 90 | Abdominal hysterectomy | Plaster therapy | ST36 acupoint | Sham: plaster on sham acupoints | NR | PCA, VAS, PONV, urinary retention, AE, satisfaction |
|
| ||||||||
| Park, | Randomized, double-blind, sham-controlled study | Randomized = 150 | Total abdominal hysterectomy | Plaster therapy | K-A20 acupoint | Sham: placebo tape at K-A20; PAS placed on the lateral thighs as in Group K | NR | Sore throat, PONV, fentanyl dose, AE |
|
| ||||||||
| Adib-Hajbaghery, | Single-blind | Randomized = 70 | Appendectomy | Acupressure | LE7 acupoint | Sham point opposite LE7 | NR | VAS, nausea, vomiting |
|
| ||||||||
| Chen, | RCT | Randomized = 104 | Cesarean section (CS) | Acupressure | P6 acupoint | Postoperative nursing | NR | DDQ, RINV, VASA, STAI, VAS |
|
| ||||||||
| Sakurai, | RCT | Randomized = 53 | Abdominal surgery | Acupressure | Nei guan, Zusanli, Sanyinjiao, and Gongsun acupoints | Standard anesthesia monitoring | NR | VAS, PONV, side effects, antiemetic requirement |
|
| ||||||||
| Felhendler, | RCT | Randomized = 40 | Knee arthroscopy | Acupressure | ST1, ST45, SP1, SP21, SP4, BL1, BL67, KI1, KI27, KI4, GB1, GB44, LR1, LR14, LR5 | 15 nonacupoints, no active stimulation | NR | VAS, cardiovascular measurements |
|
| ||||||||
| Maimer, | Prospective, randomized, controlled, observer-blinded clinical trial | Randomized = 100 | Heart surgery | Manual acupuncture | Control acupuncture: LI4, SI6, BL60, EX1, GV20, GB8, ST8 | Standard treatment with no additional acupuncture | NR | PPR, FVC |
|
| ||||||||
| Langenbach, | Patient-blind | Randomized = 50 | Stapled hemorrhoidopexy | Manual acupuncture | DU2, DU20, BI30, BI57, MA44, PE6 | Sham: needles placed away from meridians | NR | NRS, analgesics, cardiovascular parameters, complications |
|
| ||||||||
| Marra, | Pilot RCT | Randomized = 42 | Mediolateral episiotomy | Manual acupuncture | Lower 1 acupoint according to wrist-ankle acupuncture, right ankle | Standard treatment without acupuncture | NR | Oral analgesics, perineal pain, acupuncture acceptability, AE |
|
| ||||||||
| Wu, | RCT, three | Randomized = 60 | CS | Manual acupuncture, EA | SP6 | No special treatment, PCA machine applied | NR | VAS, PCA demand, AE |
|
| ||||||||
| Sertel, | Single-blind, randomized, prospective bicenter study | Randomized = 123 | Tonsillectomy | Manual acupuncture | S34, S44, PC5 | Control acupuncture: nonspecific points away from meridians | NR | VAS, AE |
|
| ||||||||
| Tsang, | Prospective patient- and assessor- | Randomized = 36 | Bilateral total knee arthroplasty | Manual acupuncture | ST32, ST33, GB31, GB35, GB34, ST36 | No needle manipulation, no inducement of or inquiry about numbness, tingling, or heaviness | NR | VAS, analgesics, ROM, timed up-and-go test |
|
| ||||||||
| Kotani, | RCT |
| Abdominal surgery | Manual acupuncture | Upper abdominal surgery: bilateral BL18–BL24 | Needles positioned at acupoints but not inserted into intradermal space | NR | VRS, analgesics, analgesic-related effects, PONV, |
|
| ||||||||
| Gupta, | Prospective, double-blind, randomized controlled | Randomized = 42 | Elective single-knee arthroscopy | Manual acupuncture | SP9, SP10, ST34, ST36s | Standard treatment | NR | VAS, analgesic requirement |
|
| ||||||||
| Lao, | Randomized, double-blind, placebo- | Randomized = 39 | Oral surgery | Manual acupuncture | LI4, ST6, ST7, SJ17 | Identical to intervention treatment but no needle insertion into skin | 7 days | Medication consumption, pain, psychological impact, AE |
|
| ||||||||
| Lao, | Randomized, single-blind, placebo- | Randomized = 22, (18–40) | Oral surgery | Manual acupuncture | LI4, ST6, ST7, SJ17s | Tapping next to acupoints to produce discernible sensation | 7 days | Pain, medication consumption, AE, local discomfort |
RCT, randomized controlled trial; APS, acupoint stimulation; EA, electroacupuncture; LF, low frequency; HF, high frequency; TEAS, transcutaneous electrical acupoint stimulation; NR, not reported; VAS, visual analog scale; PCA, patient-controlled analgesia; TAES, transcutaneous acupoint electrical stimulation; PONV, postoperative nausea and vomiting; RSS, Ramsay Sedation Scale; TENS, transcutaneous electrical nerve stimulation; HSS, New York Hospital for Special Surgery score; ROM, range of motion; MMT, manual muscle test; AES, acupoint electrical stimulation; AE, adverse effects/side effects; BPI, Brief Pain Inventory; BP, blood pressure; HR, heart rate; BCS, Bruggemann Comfort Scale; SF-36, Short Form 36; CS, cesarean section; PPR, percentile pain reduction; FVC, forced vital capacity; NRS, numerical rating scale; VRS, verbal rating scale; DDQ, Demographic Data Questionnaire; RINV, Rhodes Index of Nausea and Vomiting; VASA, Visual Analog Scale for Anxiety; STAI, State-Trait Anxiety Inventory.
Characteristics of RCTs examining auricular acupoint stimulation included in the meta-analysis.
| First author, year, setting | Study design | Participants ( | Surgery type | APS type | Intervention | Follow-up | Main | |
|---|---|---|---|---|---|---|---|---|
| Intervention group | Sham/control group | |||||||
| Zhang, 2013, China [ | RCT | Randomized = 120 | Gynecological laparoscopy | Seed | TF4, CO4, and AH6A auricular points | No sticking or pressing of vaccaria seeds | NR | PONV, VAS, tropisetron and morphine usage rates, adverse effects |
|
| ||||||||
| He, 2013, | Prospective, randomized, sham-controlled trial | Randomized = 90 | Total knee arthroplasty | Seed | Site-knee joint, Shen Men, subcortex, and sympathesis auricular points | Sham acupuncture at four nonacupoints on helix ipsilateral to surgical site | 3 months after operation | VAS, analgesic, analgesic-related adverse effects, HSS, ROM |
|
| ||||||||
| Chang, 2012, Taiwan [ | Double-blind | Randomized = 62 | Total knee arthroplasty | Seed | TF4 and AT4 auricular points | Regular care | NR | VAS, SF-MPQ, analgesic dosage, ROM |
|
| ||||||||
| Kong, 2012, | RCT | Randomized = 60 | Calcaneal fracture surgery | Seed | Shen Men, thalamus lung, liver, kidney, and knee joint auricular points | Standard treatment (PCIA) | NR | VAS, analgesic, adverse reactions, urinary retention |
|
| ||||||||
| Yeh, 2010, | Single-blind | Randomized = 94 | Lumbar spinal surgery | Seed | TF4, AT3, AH9, CO4, CO3, and CO18 auricular points | Standard treatment with no acupressure | NR | APSPOQ, pain intensity, analgesic dose, PONV, satisfaction |
|
| ||||||||
| Tsang, 2011, | Patient- and assessor-blinded RCT | Randomized = 48 | Hysterectomy | EA | Uterus, abdomen, sympathetic, Shen Men, and subcortex auricular points | Sham TENS group: 90 s stimulation at 1 Hz | NR | VAS, PEFR |
|
| ||||||||
| Kager, 2009, Austria [ | Double-blind, randomized study | Randomized = 33 | Tonsillectomy | EA | Point 55 (entrance of the spirit, Shen Men), point 29 (occiput, pillow, Zhen), and point 73 (BIAN TAO Ti 1) | Placement of acupuncture needles without stimulation, removed after 96 h | NR | VAS, NRS, oral analgesia, PONV |
|
| ||||||||
| Michalek-Sauberer, 2007, Austria [ | Prospective, randomized, double-blind, placebo- | Randomized = 149 | Unilateral mandibular third molar extraction | EA | AA points 1 (tooth), 55 (Shen Men), and 84 (mouth) | Sham AE with metal plates instead of needles, no electrical stimulation | NR | VAS, acetaminophen requirement, patient satisfaction |
|
| ||||||||
| Sator-Katzenschlager, 2006, | Prospective, randomized, double-blind, controlled study | Randomized = 94 | IVF treatment | EA | Auricular points 57 (uterus), 55 (Shen Men), and 29 (cushion) | Adhesive tape over whole ear | NR | Side effects, satisfaction, IVF outcome data |
|
| ||||||||
| Wang, 2012, | RCT | Randomized = 60 | Total knee arthroplasty | Manual | Shen Men, thalamus lung, and knee joint auricular points | Sham needle embedding at nonacupoints | NR | VAS, PONV, dizziness, drowsiness, PCA |
|
| ||||||||
| Usichenko, | Prospective, patient- and evaluator-blinded, controlled study | Randomized = 120 | Ambulatory knee surgery | Manual | Knee joint, Shen Men, and lung auricular points | Invasive needle control at three nonacupoints of helix ipsilateral to surgical site | NR | VAS, analgesia, discharge time, nighttime sleep quality, adverse events |
|
| ||||||||
| Usichenko, | Prospective, patient- and evaluator-blinded, controlled pilot study | Randomized = 20 | Ambulatory knee surgery | Manual | Knee joint, Shen Men, and lung auricular points | Invasive needle control at nonacupoints of helix ipsilateral to surgical site | NR | VAS, analgesia requirement, discharge time, night sleep, |
|
| ||||||||
| Usichenko, | Prospective randomized patient-, anesthesiologist-, evaluator-, and analyst-blinded, sham-controlled study | Randomized = 61 | Total hip arthroplasty | Manual | Hip joint, Shen Men, lung, and thalamus auricular points | Nonacupoints of helix ipsilateral to surgical site | NR | PCA demand, VAS, analgesia-related side effects |
|
| ||||||||
| Li, 1994, | Double-blind, randomized study | Randomized = 48, 48.64 (11.35) | Surgery for liver cancer | Manual | Chinese herb group: | Epidural morphine group: 2 mg epidural morphine before peritoneum suturing | NR | VAS, pethidine requirement, leucine |
RCT, randomized controlled trial; APS, acupoint stimulation; NR, not reported; PONV, postoperative nausea and vomiting; VAS, visual analog scale; HSS, New York Hospital for Special Surgery score; ROM, range of motion; PCA, patient-controlled analgesia; SF-MPQ, Short-Form McGill Pain Questionnaire; PEFR, peak expiratory flow rate; APSPOQ, American Pain Society Patient Outcome Questionnaire; TENS, transcutaneous electrical nerve stimulation; NRS, numerical rating scale; AA/A, auricular acupuncture; AE/EA, auricular electroacupuncture; IVF, in vitro fertilization.
Characteristics of RCTs examining integrative acupoint stimulation included in the meta-analysis.
| First author, year, setting | Study design | Participants ( | Surgery type | APS type | Intervention | Follow-up | Main outcomes | |
|---|---|---|---|---|---|---|---|---|
| Intervention group | Sham/control group | |||||||
| Chung, 2014, Taiwan [ | Single-blind, sham-controlled study, three groups | Enrolled = 135 | Lumbar spinal surgery | AA + EA | TF4, AH10, CW8, AT5, CO4; BL40 and GB34 acupoints | Sham group: sham acupressure and sham TAES | NR | VAS, morphine consumption, morphine-related side effects |
|
| ||||||||
| Dias, 2010, Brazil [ | Single-blind RCT | Randomized = 33 | Inguinal hernia repair | EA | Acupoints on limbs and ear (heart and Shen Men) | Sham TENS at same sites | 2 weeks | Anesthetics requirement, VAS, HR, BP, edema, adverse events |
|
| ||||||||
| Pfister, 2010, USA [ | Prospective, open-label RCT | Randomized = 70 | Neck dissection | Manual acupuncture | LI4, SP6, GV20, Luo Zhen, and auricular Shen Men acupoints | Usual care | NR | NRS, medication use, adverse events |
|
| ||||||||
| Deng, 2008, USA [ | Randomized, sham-controlled, subject-blinded trial | Randomized = 162 | Thoracotomy | Manual acupuncture | BL12–BL19, Wei Guan Xia Shu, ST36, and bilateral auricular Shen Men acupoints | Dummy studs placed in back | 3 months postoperatively | BPI, medication use, MQS, NRS |
|
| ||||||||
| Mehling, 2007, USA [ | RCT | Randomized = 138 | Cancer-related surgery | Massage + EA | Acupressure-type foot massage, large intestine 4, spleen 6, and auricular acupoints | Usual care, offered 30 min massage | NR | NRS, nausea, vomiting, POMS-SF, health care cost |
|
| ||||||||
| Tavares, 2007, Brazil [ | RCT | Randomized = 24, 20.42 (1.44) | Mandibular third molar surgery | EA | IG4, F3, E44, VB39, TA21, B60, Shen Men, and ponto total acupoints | No acupoint stimulation | NR | VAS, analgesic dose |
|
| ||||||||
| Ekblom, 1991, Sweden [ | RCT | Randomized = 110 | Mandibular third molar extraction | Manual acupuncture | ST6, ST7, S119, and LI4 acupoints ipsilateral to extraction site; SJ5 contralateral | No acupuncture | 1 week postoperatively | VAS, tension and stress, analgesic consumption, wound healing |
RCT, randomized controlled trial; APS, acupoint stimulation; AA, auricular acupuncture; EA, electroacupuncture; TAES, transcutaneous acupoint electrical stimulation; NR, not reported; VAS, visual analog scale; TENS, transcutaneous electrical nerve stimulation; BP, blood pressure; HR, heart rate; NRS, numerical rating scale; BPI, Brief Pain Inventory; MQS, Medication Quantification Scale; POMS-SF, Mood States Short Form; PRE-ACU, preoperative acupuncture; POST-ACU, postoperative acupuncture.
Figure 2Methodological quality of included studies. Each methodological quality item was qualitatively assessed and is presented as a percentage across all included studies.
Figure 3Risk of bias in the included studies. Each bias item was qualitatively assessed.
Figure 4Funnel plot.
Summary of meta-analysis results.
| Group | Outcome | Number of trials | Number of participants | Statistical method | Effect size |
| Heterogeneity |
|---|---|---|---|---|---|---|---|
| Overall effects (AM) | |||||||
| I versus ST | VAS | 20 | 1227 | Std. MD (IV, random, 95% CI) | −1.05 (−1.44, −0.67) | <0.00001 |
|
| I versus S/P | VAS | 23 | 1284 | Std. MD (IV, random, 95% CI) | −0.72 (−1.03, −0.41) | <0.00001 |
|
| Body points (AM) | VAS | 24 | 1370 | Std. MD (IV, random, 95% CI) | −0.97 (−1.32, −0.62) | <0.00001 |
|
| I versus ST | VAS | 14 | 893 | Std. MD (IV, random, 95% CI) | −1.08 (−1.54, −0.61) | <0.00001 |
|
| I versus S/P | VAS | 14 | 693 | Std. MD (IV, random, 95% CI) | −0.86 (−1.28, −0.45) | <0.0001 |
|
| Body points (EA) | VAS | 17 | 928 | Std. MD (IV, random, 95% CI) | −0.71 (−1.02, −0.40) | <0.00001 |
|
| I versus ST | VAS | 10 | 591 | Std. MD (IV, random, 95% CI) | −0.68 (−1.04, −0.32) | 0.0002 |
|
| I versus S/P | VAS | 9 | 417 | Std. MD (IV, random, 95% CI) | −0.67 (−1.13, −0.22) | 0.004 |
|
| Body points (EA)-NIN | VAS | 8 | 463 | Std. MD (IV, random, 95% CI) | −0.66 (−1.10, −0.22) | 0.003 |
|
| Body points (EA)-IN | VAS | 10 | 545 | Std. MD (IV, random, 95% CI) | −0.67 (−1.11, −0.24) | 0.002 |
|
| Body points (M) | VAS | 3 | 152 | Std. MD (IV, random, 95% CI) | −1.55 (−3.91, 0.81) | 0.20 |
|
| I versus ST | VAS | 2 | 122 | Std. MD (IV, random, 95% CI) | −2.43 (−5.49, 0.46) | 0.12 |
|
| Body points (A) | VAS | 3 | 214 | MD (IV, random, 95% CI) | −1.44 (−2.56, −0.33) | 0.01 |
|
| Body points (Pla) I versus ST | VAS | 2 | 116 | MD (IV, random, 95% CI) | −10.85 (−15.59, −6.12) | <0.00001 |
|
| Body points for AS | VAS | 8 | 471 | Std. MD (IV, random, 95% CI) | −0.67 (−1.06, −0.29) | 0.0006 |
|
| Body points for KS | VAS | 4 | 200 | Std. MD (IV, random, 95% CI) | −0.90 (−2.14, 0.34) | 0.16 |
|
| Body points for CaS | VAS | 2 | 52 | Std. MD (IV, random, 95% CI) | −0.94 (−1.52, −0.36) | 0.002 |
|
| Body points for CeS | VAS | 2 | 144 | Std. MD (IV, random, 95% CI) | −0.81 (−1.15, −0.47) | <0.00001 |
|
| I versus S/P | VAS | 2 | 116 | MD (IV, random, 95% CI) | −8.38 (−12.10, −4.65) | <0.0001 |
|
| Auricular points (AM) | VAS | 12 | 784 | Std. MD (IV, random, 95% CI) | −0.66 (−1.06, −0.25) | 0.001 |
|
| I versus ST | VAS | 4 | 225 | Std. MD (IV, random, 95% CI) | −1.23 (−2.44, −0.03) | 0.04 |
|
| I versus S/P | VAS | 9 | 591 | Std. MD (IV, random, 95% CI) | −0.56 (−1.05, −0.07) | 0.02 |
|
| Auricular points (EM) | VAS | 5 | 404 | Std. MD (IV, random, 95% CI) | −0.77 (−1.42, −0.12) | 0.02 |
|
| Auricular points (M) | VAS | 4 | 252 | Std. MD (IV, random, 95% CI) | −0.16 (−0.62, 0.30) | 0.49 |
|
| Auricular points (EA) | VAS | 3 | 128 | Std. MD (IV, random, 95% CI) | −1.11 (−1.60, −0.61) | <0.0001 |
|
| Auricular points for KS | VAS | 5 | 350 | Std. MD (IV, random, 95% CI) | −0.27 (−0.68, 0.14) | 0.20 |
|
| Auricular points for AS | VAS | 2 | 138 | Std. MD (IV, random, 95% CI) | −1.19 (−2.12, −0.26) | 0.01 |
|
| Integrative points | VAS/NRS | 6 | 444 | Std. MD (IV, random, 95% CI) | −0.61 (−1.14, −0.07) | 0.03 |
|
| Integrative points for OS | VAS | 2 | 109 | Std. MD (IV, random, 95% CI) | −1.87 (−5.69, 1.94) | 0.34 |
|
| Analgesic requirement | TMC | 6 | 399 | MD (IV, random, 95% CI) | −4.99 (−7.51, −2.47) | 0.0001 |
|
| I versus S/P | TMC | 2 | 132 | MD (IV, random, 95% CI) | −15.20 (−21.24, −9.16) | <0.00001 |
|
AM, all modalities; VAS, visual analog scale; NRS, numerical rating scale; I, intervention group; ST, standard treatment control group; S/P, sham/placebo control group; EA, electroacupuncture; NIN, noninvasive; IN, invasive; M, manual acupuncture; A, acupressure; Pla, plaster; EM, seed embedding; TMC: total morphine consumption; Std. MD, Std. mean difference; MD, mean difference; AS, abdominal surgery; KS, knee surgery; CaS, cardiac surgery; CeS, cesarean section; OS: oral surgery.
χ 2 test.
Sensitivity analysis results.
| Presensitivity analysis | Heterogeneity | Sensitivity analysis | Number of trials | Postsensitivity analysis | Heterogeneity |
|---|---|---|---|---|---|
| Effects of interventions, all body modalities versus standard treatment control (VAS) | |||||
| Random, −1.08 (−1.54, −0.61) |
| Remove Kim et al. 2009 [ | 12 ( | Random, −0.74 (−1.05, −0.43) |
|
|
| |||||
| Effects of invasive body electroacupuncture versus all controls (VAS) | |||||
| Random, −0.67 (−1.11, −0.24) |
| Remove Gilbertson et al. 2003 [ | 9 ( | Random, −0.47 (−0.79, −0.15) |
|
|
| |||||
| Effects of body electroacupuncture versus standard treatment (VAS) | |||||
| Random, −0.68 (−1.04, −0.32) |
| Remove Deng et al. 2010 [ | 8 ( | Fixed, −0.38 (−0.57, −0.20) |
|
|
| |||||
| Effects of body electroacupuncture versus sham/placebo control (VAS) | |||||
| Random, −0.67 (−1.13, −0.22) |
| Remove Gilbertson et al. 2003 [ | 8 ( | Fixed, −0.42 (−0.62, −0.21) |
|
|
| |||||
| Effects of body acupressure versus standard treatment (VAS) | |||||
| Random, −1.44 (−2.56, −0.33) |
| Remove Adib-Hajbaghery and Etri 2013 [ | 2 ( | Fixed, −1.93 (−2.33, −1.53) |
|
|
| |||||
| Overall effects of auricular interventions, all modalities versus sham/placebo control (VAS) | |||||
| Random, −0.56 (−1.05, −0.07) |
| Remove Zhang 2013 [ | 7 ( | Random, −0.23 (−0.54, 0.09) |
|
|
| |||||
| Effects of auricular manual acupuncture versus sham/placebo control (VAS) | |||||
| Random, −0.16 (−0.62, 0.30) |
| Remove Usichenko et al. 2007 [ | 3 ( | Fixed, −0.34 (−0.69, 0.00) |
|
|
| |||||
| Overall effects of integrative interventions versus all controls (VAS and NRS) | |||||
| Random, −0.61 (−1.14, −0.07) |
| Remove Tavares et al. 2007 [ | 5 ( | Fixed, −0.29 (−0.49, −0.09) |
|